Yes, the FVRCP vaccine is recommended for indoor cats. Every major veterinary organization classifies it as a core vaccine, meaning all cats should receive it regardless of lifestyle. The reason is straightforward: the diseases it protects against are severe, and indoor cats are not as isolated from them as most owners assume.
What FVRCP Protects Against
FVRCP covers three viral diseases: feline viral rhinotracheitis (caused by feline herpesvirus), calicivirus, and panleukopenia (sometimes called feline distemper). Each poses a different level of threat.
Panleukopenia is the most dangerous of the three. It attacks the gut and immune system, causing severe vomiting, diarrhea, and a dramatic drop in white blood cells. Mortality rates in unvaccinated cats range from 25% to 90% for acute infections, and kittens fare even worse. This virus is the primary reason veterinarians insist on FVRCP for every cat.
Rhinotracheitis and calicivirus are upper respiratory infections. They cause sneezing, nasal discharge, mouth ulcers, and fever. While they’re rarely fatal in healthy adult cats, they can become chronic. Feline herpesvirus, once contracted, stays in the body for life and can flare up during stress. The vaccine doesn’t fully prevent infection from these two viruses, but it significantly reduces how sick a cat gets and how long symptoms last.
How Indoor Cats Get Exposed
The assumption behind the question is understandable: if your cat never goes outside, how would it encounter these viruses? The answer is that you bring the outside in.
Panleukopenia virus is extraordinarily hardy. It can survive for a year or more on surfaces and resists most common household disinfectants. According to guidelines published in the Journal of Feline Medicine and Surgery, indirect contact through fomites like shoes and clothing is actually the most common route of infection, which means indoor cats are also at risk. You could track the virus into your home on the bottom of your shoes after walking through an area where an infected cat has been.
Calicivirus is less persistent but still survives on everyday objects. Research has shown it can live up to three days on phone surfaces and one to two days on items like a computer mouse. While that’s a shorter window, it’s more than enough time for transfer to happen if you’ve handled another cat or visited a place where cats are present.
There are also scenarios owners don’t always plan for. A window screen tears and a cat escapes. You foster or adopt a second cat. A friend visits with a cat carrier. Your cat needs to be boarded during a family emergency. Any of these situations can introduce exposure, and by then it’s too late to start a vaccine series.
The Vaccination Schedule
Kittens receive their initial FVRCP series as a set of shots given every two to four weeks, starting around 8 to 10 weeks of age and continuing until 16 to 20 weeks. This series is essential because kittens are born with temporary antibodies from their mother that gradually fade. The repeated doses ensure the kitten’s own immune system picks up where maternal protection leaves off. Skipping or delaying this series leaves a dangerous gap.
After the kitten series, an adult booster is given about one year later, typically around 16 to 20 months of age. From that point on, boosters are recommended every three years for low-risk indoor cats. That three-year interval reflects the minimum known duration of immunity from the vaccine, though many cats maintain protection for much longer.
Titer Testing as an Alternative to Boosters
If you’re concerned about vaccinating more often than necessary, antibody titer testing is an option for adult cats. A blood test measures whether your cat still has protective antibody levels from previous vaccinations. If antibodies are present, revaccination isn’t needed.
This approach works well for panleukopenia. Many vaccinated cats maintain protective antibody levels for years, sometimes for life, so triennial boosters may be unnecessary for some individuals. Revaccination has been shown to offer no additional benefit in cats that already have high antibody levels.
The picture is less clear for the other two viruses. For calicivirus and herpesvirus, the correlation between antibody levels and actual protection is weaker, making titer results harder to interpret for those components.
The practical tradeoff is cost and convenience. Titer tests are more expensive than the vaccine itself, and they require a blood draw. For most indoor cat owners, sticking with the every-three-year booster schedule is simpler and provides reliable protection across all three diseases.
Vaccine Side Effects and Risks
Serious reactions to FVRCP are rare. In large studies, adverse events within 30 days of vaccination occurred in about 0.52% of cats. The most common reaction is mild lethargy or reduced appetite lasting a few days. Anaphylaxis, the most severe possible reaction, occurs in roughly one out of every 555,000 vaccinated cats.
The concern that comes up most often is injection-site sarcoma, a type of tumor that can develop where vaccines are administered. This is a real but uncommon risk, estimated at one to four cases per 10,000 vaccinated cats in the United States. To put that in perspective, the fatality rate from panleukopenia in unvaccinated cats is many times higher than the incidence of this tumor in vaccinated ones. Veterinarians also take steps to reduce this risk by using specific injection sites on the limbs rather than between the shoulder blades, making any tumor easier to treat if one ever develops.
About 10% of cats in one study developed mildly reduced energy for a few days after vaccination, which was actually correlated with a stronger immune response. In other words, a slightly sluggish cat after a vaccine visit is a normal sign that the immune system is doing its job.
Why the Risk-Benefit Favors Vaccination
The core calculation is simple. Panleukopenia can kill a healthy cat within days, and the virus can reach your indoor cat through nothing more than your shoes. The vaccine that prevents it causes serious side effects in a tiny fraction of cats and needs to be given only once every three years after the initial series. Even if you consider injection-site sarcoma, the worst possible vaccine complication, its incidence is orders of magnitude lower than the mortality rate of the disease it prevents.
For rhinotracheitis and calicivirus, the stakes are lower since these infections are rarely fatal. But chronic herpesvirus flare-ups can mean recurring eye infections, congestion, and veterinary bills for the rest of your cat’s life. Reducing the severity of these infections through vaccination saves both suffering and money over the long term.